Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Nov;74(10):1660–1667. doi: 10.1038/bjc.1996.606

Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).

J Bernhard 1, C Hürny 1, M Bacchi 1, R A Joss 1, F Cavalli 1, H J Senn 1, S Leyvraz 1, R Stahel 1, C Ludwig 1, P Alberto 1
PMCID: PMC2074835  PMID: 8932352

Abstract

The question of whether initial prognostic factors in small-cell lung cancer patients have a predictive value for patients' quality of life (QL) during chemotherapy is addressed in the context of a randomised clinical trial comparing early and late alternating chemotherapy (SAKK protocol 15/84). The relative impact of initial tumour stage and performance status, previous weight loss, sex and age on patient-rated QL was analysed over six chemotherapy cycles in 124-130 patients (according to available QL data) with more than 400 questionnaires. Fatigue/malaise, personal functioning, emotional and general well-being were prospectively selected as QL indicators. Predefined summary measures (average QL score over chemotherapy cycles, 'minimum', 'maximum' and 'final' improvement) were analysed separately by scale in various patient groups. General linear models adjusted for treatment arm and response were used to confirm the univariate findings. Within the overall sample, the average QL scores over six cycles were predicted by initial prognostic factors. Patients with poor prognostic factors reported worse QL. Within a limited sample (with baseline QL), patients with poor prognostic factors reported worse QL at baseline and greater improvement under treatment. Graphical comparison of QL patterns over cycles showed permanent discrimination by levels of prognostic factors. The impact of initial prognostic factors was consistently confirmed in the three analyses. Levels of performance status and weight loss best discriminated QL. Initial tumour stage, performance status and previous weight loss can predict QL in small-cell lung cancer during chemotherapy, even after controlling for response to treatment. Our results may contribute to clinical decision-making with regard to the intensity of chemotherapy and QL outcome, especially in patients with extensive disease.

Full text

PDF
1660

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergman B., Aaronson N. K. Quality-of-life and cost-effectiveness assessment in lung cancer. Curr Opin Oncol. 1995 Mar;7(2):138–143. doi: 10.1097/00001622-199503000-00008. [DOI] [PubMed] [Google Scholar]
  2. Bernhard J., Ganz P. A. Psychosocial issues in lung cancer patients. Cancer Treat Res. 1995;72:363–390. doi: 10.1007/978-1-4615-2630-8_17. [DOI] [PubMed] [Google Scholar]
  3. Blanchard C. G., Labrecque M. S., Ruckdeschel J. C., Blanchard E. B. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med. 1988;27(11):1139–1145. doi: 10.1016/0277-9536(88)90343-7. [DOI] [PubMed] [Google Scholar]
  4. Bleehen N. M., Girling D. J., Machin D., Stephens R. J. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party. Br J Cancer. 1993 Dec;68(6):1157–1166. doi: 10.1038/bjc.1993.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cella D. F., Orofiamma B., Holland J. C., Silberfarb P. M., Tross S., Feldstein M., Perry M., Maurer L. H., Comis R., Orav E. J. The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer. 1987 Oct 1;60(7):1661–1667. doi: 10.1002/1097-0142(19871001)60:7<1661::aid-cncr2820600740>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  6. Coates A., Gebski V., Bishop J. F., Jeal P. N., Woods R. L., Snyder R., Tattersall M. H., Byrne M., Harvey V., Gill G. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med. 1987 Dec 10;317(24):1490–1495. doi: 10.1056/NEJM198712103172402. [DOI] [PubMed] [Google Scholar]
  7. Davis C. S. Semi-parametric and non-parametric methods for the analysis of repeated measurements with applications to clinical trials. Stat Med. 1991 Dec;10(12):1959–1980. doi: 10.1002/sim.4780101210. [DOI] [PubMed] [Google Scholar]
  8. Earl H. M., Rudd R. M., Spiro S. G., Ash C. M., James L. E., Law C. S., Tobias J. S., Harper P. G., Geddes D. M., Eraut D. A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer. 1991 Sep;64(3):566–572. doi: 10.1038/bjc.1991.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fletcher A., Gore S., Jones D., Fitzpatrick R., Spiegelhalter D., Cox D. Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ. 1992 Nov 7;305(6862):1145–1148. doi: 10.1136/bmj.305.6862.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ganz P. A., Schag C. A., Lee J. J., Sim M. S. The CARES: a generic measure of health-related quality of life for patients with cancer. Qual Life Res. 1992 Feb;1(1):19–29. doi: 10.1007/BF00435432. [DOI] [PubMed] [Google Scholar]
  11. Gower N. H., Rudd R. M., Ruiz de Elvira M. C., Spiro S. G., James L. E., Harper P. G., Souhami R. L. Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer. Ann Oncol. 1995 Jul;6(6):575–580. doi: 10.1093/oxfordjournals.annonc.a059247. [DOI] [PubMed] [Google Scholar]
  12. Hopwood P., Stephens R. J., Machin D. Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial. Qual Life Res. 1994 Oct;3(5):339–352. doi: 10.1007/BF00451726. [DOI] [PubMed] [Google Scholar]
  13. Hopwood P., Thatcher N. Preliminary experience with quality of life evaluation in patients with lung cancer. Oncology (Williston Park) 1990 May;4(5):158–171. [PubMed] [Google Scholar]
  14. Hürny C., Bernhard J., Joss R., Willems Y., Cavalli F., Kiser J., Brunner K., Favre S., Alberto P., Glaus A. Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK. Ann Oncol. 1992 Dec;3(10):825–831. doi: 10.1093/oxfordjournals.annonc.a058104. [DOI] [PubMed] [Google Scholar]
  15. Joss R. A., Alberto P., Hürny C., Bacchi M., Leyvraz S., Thürlimann B., Cerny T., Martinelli G., Stahel R., Ludwig C. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol. 1995 Jan;6(1):41–48. doi: 10.1093/oxfordjournals.annonc.a059039. [DOI] [PubMed] [Google Scholar]
  16. Joss R. A., Bacchi M., Hürny C., Bernhard J., Cerny T., Martinelli G., Leyvraz S., Senn H. J., Stahel R., Siegenthaler P. Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol. 1995 Feb;6(2):157–166. doi: 10.1093/oxfordjournals.annonc.a059111. [DOI] [PubMed] [Google Scholar]
  17. Matthews J. N. A refinement to the analysis of serial data using summary measures. Stat Med. 1993 Jan 15;12(1):27–37. doi: 10.1002/sim.4780120105. [DOI] [PubMed] [Google Scholar]
  18. Tandon P. K. Applications of global statistics in analysing quality of life data. Stat Med. 1990 Jul;9(7):819–827. doi: 10.1002/sim.4780090711. [DOI] [PubMed] [Google Scholar]
  19. Wolf M., Pritsch M., Drings P., Hans K., Schroeder M., Flechtner H., Heim M., Hruska D., Mende S., Becker H. Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients. J Clin Oncol. 1991 Apr;9(4):614–624. doi: 10.1200/JCO.1991.9.4.614. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES